EN — 简 — FR
INTERNAL DRUG DISCOVERY
AND DEVELOPMENT PIPELINE
Insilico Medicine's PHARMA.AI Platforms
Revolutionize Drug Discovery and Development
Target X*
PHD2
QPCTL
MAT2A
3CL
KAT6A
DGKA
PRO
CDK12
ENPP1
USP1
TARGET X* — Not available for licensing.

Contact bd@insilicomedicine.com for partnering opportunities
Target
Co-development with Fosun
Phase 2
Phase 1
IND-enabling
Discovery
Stage of development
indication
Inflammatory Bowel Disease
Anemia of Chronic Kidney Disease
Skin Fibrosis
Solid tumors
COVID-19
Solid tumors
BRCA-mutant cancer
Solid tumors
MTAP-/- cancer
ER+Breast cancer, AML
Immuno-Oncology
Kidney Fibrosis
Idiopathic Pulmonary Fibrosis
Other
Oncology
Immunology
Fibrosis